mCRISPRa-v2, genome-wide, top 5 sgRNAs/gene Citations (3)

Originally described in: Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation.
Horlbeck MA, Gilbert LA, Villalta JE, Adamson B, Pak RA, Chen Y, Fields AP, Park CY, Corn JE, Kampmann M, Weissman JS Elife. 2016 Sep 23;5. pii: e19760. doi: 10.7554/eLife.19760. PubMed Journal

---

Articles Citing mCRISPRa-v2, genome-wide, top 5 sgRNAs/gene

Articles
In vivo CRISPR screening identifies BAZ2 chromatin remodelers as druggable regulators of mammalian liver regeneration. Jia Y, Li L, Lin YH, Gopal P, Shen S, Zhou K, Yu X, Sharma T, Zhang Y, Siegwart DJ, Ready JM, Zhu H. Cell Stem Cell. 2022 Mar 3;29(3):372-385.e8. doi: 10.1016/j.stem.2022.01.001. Epub 2022 Jan 31. PubMed
Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment. Yabushita T, Chinen T, Nishiyama A, Asada S, Shimura R, Isobe T, Yamamoto K, Sato N, Enomoto Y, Tanaka Y, Fukuyama T, Satoh H, Kato K, Saitoh K, Ishikawa T, Soga T, Nannya Y, Fukagawa T, Nakanishi M, Kitagawa D, Kitamura T, Goyama S. Cell Rep. 2023 Sep 26;42(9):113098. doi: 10.1016/j.celrep.2023.113098. Epub 2023 Sep 14. PubMed
MCRS1 sensitizes T cell-dependent immunotherapy by augmenting MHC-I expression in solid tumors. Li X, Yi H, Jin Z, Jiang K, Xue K, Wang J, Qian Y, Xiang Q, Zhu S, Yan R, Yang Y, Sun S, Li K, Zhou Z, Yu W, Jiang N, Ding C, Lin X, Zhong J, Dong Y, Liu Y, Yu X. J Exp Med. 2024 Dec 2;221(12):e20240959. doi: 10.1084/jem.20240959. Epub 2024 Nov 15. PubMed

If you have published an article using this material, please email us at to have your article added to this page.